Actinium Pharmaceuticals (ATNM) Net Equity Issued and Repurchased (2013 - 2024)
Actinium Pharmaceuticals (ATNM) reported Net Equity Issued and Repurchased of -$1,000 for Q4 2024, compared with $1.19 million a year earlier.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Net Equity Issued and Repurchased (2013 - 2024) Analysis & Trends
For FY2024, Actinium Pharmaceuticals posted Net Equity Issued and Repurchased of $29.26 million, up 100.2% from FY2023.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of 12.9% (FY2019 to FY2024).
- By year, Net Equity Issued and Repurchased came in at $14.61 million in FY2023 (-36.9%), $23.16 million in FY2022, $6,000 in FY2021 (-100.0%) and $76.59 million in FY2020 (+380.7%).
- The Q4 2024 figure ranks as the lowest quarterly Net Equity Issued and Repurchased since Q2 2018.
- Per Business Quant data, the three quarters before Q4 2024 came in at $4.6 million (Q3 2024), $9.96 million (Q2 2024) and $14.7 million (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Actinium Pharmaceuticals | 36.16 Mn | 36.16 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -1,000.00 |
| Sep 30, 2024 | 4.60 Mn |
| Jun 30, 2024 | 9.96 Mn |
| Mar 31, 2024 | 14.70 Mn |
| Dec 31, 2023 | 1.19 Mn |
| Sep 30, 2023 | 2.86 Mn |
| Jun 30, 2023 | 9.79 Mn |
| Mar 31, 2023 | 770,000.00 |
| Dec 31, 2022 | 4.89 Mn |
| Dec 31, 2020 | 21.88 Mn |
| Sep 30, 2020 | -134,000.00 |
| Dec 31, 2019 | 14.43 Mn |
| Jun 30, 2019 | 238.00 |
| Mar 31, 2019 | 1.50 Mn |
| Sep 30, 2018 | 3,949.00 |
| Jun 30, 2018 | -14.87 Mn |
| Mar 31, 2018 | 14.87 Mn |
| Dec 31, 2017 | 27,529.00 |
| Sep 30, 2017 | 14.96 Mn |
| Jun 30, 2017 | 1.91 Mn |
API Access
Actinium Pharmaceuticals Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();